| For: | Sun CM, Wu J, Zhang H, Shi G, Chen ZT. Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn’s disease. World J Gastroenterol 2017; 23(44): 7888-7898 [PMID: 29209130 DOI: 10.3748/wjg.v23.i44.7888] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i44/7888.htm |
| Number | Citing Articles |
| 1 |
Sepideh Seif, Narges Afra, Esmaeel Dadgar, Shabnam Enteghad, Pendar Argani, Noura Aghdasi, Sahand Saeidpour Masouleh, Ghasem Barati. The expression of salivary microRNAs in oral lichen planus: Searching for a prognostic biomarker. Pathology - Research and Practice 2022; 234 doi: 10.1016/j.prp.2022.153923
|
| 2 |
Michel Desjarlais, Maëlle Wirth, Isabelle Lahaie, Pakiza Ruknudin, Pierre Hardy, Alain Rivard, Sylvain Chemtob. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.602999
|
| 3 |
Eman Eissa, Botros Morcos, Rania Fawzy Mahmoud Abdelkawy, Hanan H Ahmed, Naglaa M Kholoussi. Association of microRNA-125a with the clinical features, disease activity and inflammatory cytokines of juvenile-onset lupus patients. Lupus 2021; 30(7) doi: 10.1177/09612033211010328
|
| 4 |
Shenglan Ye, Shan Zhu, Lijuan Feng. LncRNA ANRIL/miR‐125a axis exhibits potential as a biomarker for disease exacerbation, severity, and inflammation in bronchial asthma. Journal of Clinical Laboratory Analysis 2020; 34(3) doi: 10.1002/jcla.23092
|
| 5 |
Meiyuan Yang, Xiaoli Tang, Zheng Wang, Xiaoqing Wu, Dong Tang, Daorong Wang. miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ. Bioscience Reports 2019; 39(12) doi: 10.1042/BSR20190193
|
| 6 |
Junfeng Yang, Shanfu Wang, Lei Liu, Jianwei Wang, Yang Shao. Long non‐coding RNA NEAT1 and its targets (microRNA‐21 and microRNA‐125a) in rheumatoid arthritis: Altered expression and potential to monitor disease activity and treatment outcome. Journal of Clinical Laboratory Analysis 2021; 35(12) doi: 10.1002/jcla.24076
|
| 7 |
Zhichen Pu, Yuan Che, Weiwei Zhang, Hui Sun, Tuo Meng, Haitang Xie, Lijuan Cao, Haiping Hao. Dual roles of IL-18 in colitis through regulation of the function and quantity of goblet cells. International Journal of Molecular Medicine 2019; doi: 10.3892/ijmm.2019.4156
|
| 8 |
Danna Zhao, Shilei Li, Jie Cui, Lizeng Wang, Xiaohua Ma, Yong Li. Plasma miR‐125a and miR‐125b in sepsis: Correlation with disease risk, inflammation, severity, and prognosis. Journal of Clinical Laboratory Analysis 2020; 34(2) doi: 10.1002/jcla.23036
|
| 9 |
Hoda Y. Abdallah, Rasha Mohamed Helmy Elkaffas, Sarah Ahmed Aglan. miRNAs, Human Health and Diseases. Epigenetics and Human Health 2024; 13 doi: 10.1007/978-3-031-64788-8_8
|
| 10 |
Rania Fawzy Mahmoud Abdelkawy, Shams Kholoussi, Eman Eissa, Khaled Hamed, Haiam Abdel Raouf, Hala T. El-Bassyouni. Differential Expression of micro RNAs and their Association with the Inflammatory Markers in Familial Mediterranean Fever Patients. Biomedical and Pharmacology Journal 2021; 14(3) doi: 10.13005/bpj/2236
|
| 11 |
Ahlam Chaaban, Zeina Salman, Louna Karam, Philippe Hussein Kobeissy, José-Noel Ibrahim. Updates on the role of epigenetics in familial mediterranean fever (FMF). Orphanet Journal of Rare Diseases 2024; 19(1) doi: 10.1186/s13023-024-03098-w
|
| 12 |
. 2019; doi: 10.70675/4ac13bd9zbf56z4ff7za4b8zd2904548ff51
|
| 13 |
Xiaoping Zhu. MiR‐125b but not miR‐125a is upregulated and exhibits a trend to correlate with enhanced disease severity, inflammation, and increased mortality in sepsis patients. Journal of Clinical Laboratory Analysis 2020; 34(3) doi: 10.1002/jcla.23094
|
| 14 |
Mai Abdel Haleem Abusalah, Moad Khalifa, Mohammad A. I. Al-Hatamleh, Mu’taman Jarrar, Rohimah Mohamud, Yean Yean Chan. Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm. Journal of Personalized Medicine 2022; 12(3) doi: 10.3390/jpm12030386
|
| 15 |
Qiongxiang Ge, Yuan Dong, Guoqiang Lin, Yi Cao. Long Noncoding RNA Antisense Noncoding RNA in the INK4 Locus Correlates With Risk, Severity, Inflammation and Infliximab Efficacy in Crohn's Disease. The American Journal of the Medical Sciences 2019; 357(2) doi: 10.1016/j.amjms.2018.10.016
|
| 16 |
Shilei Li, Danna Zhao, Jie Cui, Lizeng Wang, Xiaohua Ma, Yong Li. Correlation of microRNA‐125a/b with acute respiratory distress syndrome risk and prognosis in sepsis patients. Journal of Clinical Laboratory Analysis 2020; 34(3) doi: 10.1002/jcla.23098
|
| 17 |
Xunru Huang, Yijuan Lin, Xueyan Zheng, Chengdang Wang. MiRNA-338-5p reduced inflammation through TXNIP/NLRP3 inflammasome axis by CXCR4 in DSS-induced colitis. Molecular & Cellular Toxicology 2020; 16(2) doi: 10.1007/s13273-019-00060-x
|
| 18 |
Mohamed J. Saadh, Maria V. Mikhailova, Soheil Rasoolzadegan, Mojgan Falaki, Roozbeh Akhavanfar, José Luis Arias Gonzáles, Amir Rigi, Bahman Abedi Kiasari. Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy. European Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01008-7
|
| 19 |
Dan Pei, Jingjing Cao, Guifang Qin, Xue Wang. Measurement of circulating miRNA‐125a exhibits good value in the management of etanercept‐treated psoriatic patients. The Journal of Dermatology 2020; 47(2) doi: 10.1111/1346-8138.15157
|
| 20 |
Lina Sun, Yanan Han, Hua Wang, Huanyu Liu, Shan Liu, Hongbin Yang, Xiaoxia Ren, Ying Fang. MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis. Journal of International Medical Research 2022; 50(4) doi: 10.1177/03000605221089503
|
| 21 |
Jun Li, Ji‐Zhi Xu, Bo Dou, Teng‐Fei Huang, Jie Chen, Tuan‐Mei Wang, Hong‐Juan Ouyang. Circ_0001666 upregulation promotes intestinal epithelial cell fibrosis in pediatric Crohn's disease via the SRSF1/BMP7 axis. The Kaohsiung Journal of Medical Sciences 2023; 39(10) doi: 10.1002/kjm2.12734
|
| 22 |
Kostas A. Triantaphyllopoulos, Nikolia D. Ragia, Maria-Chara E. Panagiotopoulou, Thomae G. Sourlingas. Integrating Inflammatory and Epigenetic Signatures in IBD-Associated Colorectal Carcinogenesis: Models, Mechanisms, and Clinical Implications. International Journal of Molecular Sciences 2025; 26(19) doi: 10.3390/ijms26199498
|
| 23 |
Paulius Jonaitis, Vytautas Kiudelis, Greta Streleckiene, Rolandas Gedgaudas, Jurgita Skieceviciene, Juozas Kupcinskas. Novel Biomarkers in the Diagnosis of Benign and Malignant Gastrointestinal Diseases. Digestive Diseases 2022; 40(1) doi: 10.1159/000515522
|
| 24 |
Yue Xu, Hao-Yu Li, Lang Cai, Shi-Chen Xie, Yang Zou, Xing-Quan Zhu, Wen-Bin Zheng. Differential Spleen miRNA Expression Profile of Beagle Dogs Infected with Toxocara canis. Animals 2022; 12(19) doi: 10.3390/ani12192638
|
| 25 |
Marcela A. Cucher, Mara Mariconti, Tommaso Manciulli, Ambra Vola, Mara C. Rosenzvit, Klaus Brehm, Laura Kamenetzky, Enrico Brunetti. Circulating Small RNA Profiling of Patients with Alveolar and Cystic Echinococcosis. Biology 2023; 12(5) doi: 10.3390/biology12050715
|
| 26 |
Vytautas Kiudelis, Juozas Kupcinskas, Alexander Link. Circulating and faecal microRNAs as non-invasive biomarkers for IBD: current evidence and next steps. Best Practice & Research Clinical Gastroenterology 2025; 78 doi: 10.1016/j.bpg.2025.102064
|
| 27 |
Terrence S. Furey, Praveen Sethupathy, Shehzad Z. Sheikh. Redefining the IBDs using genome-scale molecular phenotyping. Nature Reviews Gastroenterology & Hepatology 2019; 16(5) doi: 10.1038/s41575-019-0118-x
|
| 28 |
Marta Fumagalli, Marta Lombardi, Pierre Gressens, Claudia Verderio. How to reprogram microglia toward beneficial functions. Glia 2018; 66(12) doi: 10.1002/glia.23484
|
| 29 |
Hebatallah Ahmed Mohamed Moustafa, Elsayed G.E. Elsakka, Ahmed I. Abulsoud, Shereen Saeid Elshaer, Ahmed A. Rashad, Walaa A. El-Dakroury, Al-Aliaa M. Sallam, Nehal I. Rizk, Mohamed Bakr Zaki, Rania M. Gomaa, Ahmed E. Elesawy, Osama A. Mohammed, Sherif S. Abdel Mageed, Ali M.S. Eleragi, Jasmine A. ElBoghdady, Shaimaa H. El-Fayoumi, Mustafa Ahmed Abdel-Reheim, Ahmed S. Doghish. The miRNA Landscape in Crohn's disease: Implications for novel therapeutic approaches and interactions with Existing therapies. Experimental Cell Research 2024; 442(2) doi: 10.1016/j.yexcr.2024.114234
|
| 30 |
Shukur Wasman Smail, Sarah Mousa Hirmiz, Akhter Ahmed Ahmed, Niaz Albarzinji, Harem Khdir Awla, Kawa Amin, Christer Janson. Decoding the intricacies: a comprehensive analysis of microRNAs in the pathogenesis, diagnosis, prognosis and therapeutic strategies for COVID-19. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1430974
|
| 31 |
Marta Seco-Cervera, Laura Gisbert-Ferrándiz, Dulce C. Macias-Ceja, Dolores Ortiz-Masiá, Jesús Cosín-Roger, Cristina Bauset, Begoña Heras-Moran, Francisco Navarro-Vicente, Maria Civera-Barrachina, José Santiago Ibáñez-Cabellos, Sara Calatayud, María D. Barrachina, Kai Huang. Down-regulation of MIR-378A-3P expression associated with inflammation: The effects of restoring its levels. PLOS One 2025; 20(8) doi: 10.1371/journal.pone.0329685
|
| 32 |
. 2018; doi: 10.70675/c097685fz4bd0z45caz8aabz6efd0e75852d
|